Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01942993
Title The Effects of Treatment With Vemurafenib on the Immune System in Advanced Melanoma
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Philip Friedlander
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Icahn School of Medicine at Mount Sinai New York New York 11103 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field